These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cimetidine and fat malabsorption in children with cystic fibrosis. Schöni M; Kraemer R; Rossi E Helv Paediatr Acta; 1981 Sep; 36(4):359-69. PubMed ID: 7024207 [TBL] [Abstract][Full Text] [Related]
23. [Treatment of malabsorption]. Weijers HA Maandschr Kindergeneeskd; 1969 Oct; 37(4):110-2. PubMed ID: 5345410 [No Abstract] [Full Text] [Related]
24. Malabsorption of medium-chain triglycerides in infants with cystic fibrosis: correction with pancreatic enzyme supplement. Durie PR; Newth CJ; Forstner GG; Gall DG J Pediatr; 1980 May; 96(5):862-4. PubMed ID: 7365588 [No Abstract] [Full Text] [Related]
26. Faecal bile acid and dietary residue excretion in cystic fibrosis: age group variations. Walters MP; Littlewood JM J Pediatr Gastroenterol Nutr; 1998 Sep; 27(3):296-300. PubMed ID: 9740200 [TBL] [Abstract][Full Text] [Related]
27. Abnormal intracellular lipid processing contributes to fat malabsorption in cystic fibrosis patients. Peretti N; Roy CC; Drouin E; Seidman E; Brochu P; Casimir G; Levy E Am J Physiol Gastrointest Liver Physiol; 2006 Apr; 290(4):G609-15. PubMed ID: 16223944 [TBL] [Abstract][Full Text] [Related]
28. Taurine improves the absorption of a fat meal in patients with cystic fibrosis. Belli DC; Levy E; Darling P; Leroy C; Lepage G; Giguère R; Roy CC Pediatrics; 1987 Oct; 80(4):517-23. PubMed ID: 3658570 [TBL] [Abstract][Full Text] [Related]
29. A study of fat absorption in cystic fibrosis patients and controls by a rapid micro procedure: a comparison with fecal fat excretion method. Kutty KM; Bridger H; Vaze D; Davis AJ Clin Biochem; 1983 Oct; 16(5):303-5. PubMed ID: 6652887 [TBL] [Abstract][Full Text] [Related]
30. Effect of Oral Lipid Matrix Supplement on Fat Absorption in Cystic Fibrosis: A Randomized Placebo-Controlled Trial. Stallings VA; Schall JI; Maqbool A; Mascarenhas MR; Alshaikh BN; Dougherty KA; Hommel K; Ryan J; Elci OU; Shaw WA J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):676-680. PubMed ID: 27050056 [TBL] [Abstract][Full Text] [Related]
31. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice. Littlewood JM Postgrad Med J; 1996 Mar; 72 Suppl 2():S56-62; discussion S59-62. PubMed ID: 8869184 [No Abstract] [Full Text] [Related]
32. Comparison of steatocrit and fat absorption in persons with cystic fibrosis. Wagner MH; Bowser EK; Sherman JM; Francisco MP; Theriaque D; Novak DA J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):202-5. PubMed ID: 12187298 [TBL] [Abstract][Full Text] [Related]
33. [Comparison of 2 pancreatic enzyme preparations in the treatment of digestive insufficiency in mucoviscidosis (cystic fibrosis)]. Gottschalk B; Wiesemann HG; Stephan U Monatsschr Kinderheilkd; 1988 Sep; 136(9):626-9. PubMed ID: 3237230 [TBL] [Abstract][Full Text] [Related]
34. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis. Laiho KM; Gavin J; Murphy JL; Connett GJ; Wootton SA Clin Nutr; 2004 Jun; 23(3):347-53. PubMed ID: 15158298 [TBL] [Abstract][Full Text] [Related]
35. Taurine supplementation, fat absorption, and growth in cystic fibrosis. Thompson GN; Robb TA; Davidson GP J Pediatr; 1987 Oct; 111(4):501-6. PubMed ID: 3309233 [TBL] [Abstract][Full Text] [Related]
36. Minimal bile acid malabsorption. Roy CC; Weber AM Gastroenterology; 1977 Sep; 73(3):631-2. PubMed ID: 892364 [No Abstract] [Full Text] [Related]